New Delhi, April 27 -- Sun Pharma share price rose as much as 5% to Rs.1,704 in Monday's trading session after the company announced a mega deal with US-listed Organon.

The largest drug-maker stock opened at Rs.1,625 today, as compared to the previous close of Rs.1,620 on Friday last week.

In an exchange filing on Monday, Sun Pharma said that it has entered into a definitive agreement to acquire US-listed Organon. The deal is aimed at driving sustained long-term value creation and leveraging complementary portfolios to strengthen its business position.

Sun Pharma said it will acquire 100% of Organon's outstanding equity at an enterprise value of $11.75 billion, according to an exchange filing.

Organon is a global healthcare firm that ...